Trial intelligence / Profile preview

Clinical significance of acid rebound after pantoprazole in functional dyspepsia

2011-000059-17Phase 4Terminated

Sponsor
Zealand University Hospital
Start
Feb 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in functional dyspepsia (FD) and gastroesophageal reflux disease (GERD) comparing Pantoprazole with Placebo (2 arms). Started Feb 2011; status: terminated.

02

Drugs

pantoprazole
03

Conditions

functional dyspepsia (FD)gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on 2011-000059-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000059-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call